| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |